Bionema launches cold-tolerant NemaGen to support turf industry
The UK natural turf sector, valued at approximately USD 501 million in 2024 and projected to continue growing, is facing sustained pressure from crane fly and chafer larvae, following the withdrawal of chlorpyrifos and imidacloprid from amenity use.
Sign in to continue
Need to activate your subscription?
Already a subscriber
If you haven't already, activate your subscription here>>
Company Domain Access
If your company or university has a corporate subscription simply register your email address here to gain access